Cargando…
Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
Autores principales: | Michmerhuizen, Anna R., Lerner, Lynn M., Pesch, Andrea M., Ward, Connor, Schwartz, Rachel, Wilder-Romans, Kari, Liu, Meilan, Nino, Charles, Jungles, Kassidy, Azaria, Ruth, Jelley, Alexa, Zambrana Garcia, Nicole, Harold, Alexis, Zhang, Amanda, Wharram, Bryan, Hayes, Daniel F., Rae, James M., Pierce, Lori J., Speers, Corey W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021183/ https://www.ncbi.nlm.nih.gov/pubmed/35444242 http://dx.doi.org/10.1038/s41523-022-00418-w |
Ejemplares similares
-
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
por: Michmerhuizen, Anna R., et al.
Publicado: (2022) -
RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes
por: Pesch, Andrea M., et al.
Publicado: (2022) -
Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression
por: Pesch, Andrea M., et al.
Publicado: (2022) -
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer
por: Michmerhuizen, Anna R., et al.
Publicado: (2022) -
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)